- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03922854
Monitoring of Babies' Heart Rates During Labour Using Mobile Monitors
June 20, 2022 updated by: Sheffield Teaching Hospitals NHS Foundation Trust
Determining the Predictive Utility of Short-term Variation (STV) of Fetal Heart Rate (FHR) for Fetal Acidaemia, and the Feasibility of Using This for Decision Making in High-risk Women During Labour
The study has been designed as a prospective, non-randomised, single centre study to determine the predictive utility of Short Term Variation (STV) of the Fetal Heart Rate (FHR)from the intrapartum FHR data collected using the portable fetal ECG monitor (Monica AN24) in women requiring continuous monitoring during labour due to antenatal or intrapartum risk factors.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S10 2JF
- Jessop Wing Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant population
Description
Inclusion Criteria:
- Singleton term pregnant labouring women during established labour (cervix >3cm dilated, regular uterine contractions >3:10 minutes)
- Written informed consent
- At least 18 years of age
Exclusion Criteria:
- Preterm labouring women
- Multiple pregnancy
- Involved in another study using a device or medicinal product
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mobile Monitor Group
Participants are recruited to this study if they have been monitored during their labour with a monica AN 24 monitor
|
There is no clinical intervention.
This study is just capturing data from devices used part of routine clinical care.
The results of this data collection will be analysed to inform study results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sample Size
Time Frame: Recruitment period January 2018-April 2019
|
This is a feasibility study with a primary objective to establish design of a large multi-centre study.
Outcome measure is percentage number of participants to have a umbilical blood cord gas PH level below 7.20.
This will inform the statistical sample for the larger study.
|
Recruitment period January 2018-April 2019
|
Recruitment Rate
Time Frame: Recruitment period January 2018-April 2019
|
This is a feasibility study with a primary objective to establish design of a large multi-centre study.
Outcome measure is how many participants recruited per month this will inform how many centre's will be required to deliver statistical sample size for larger study.
|
Recruitment period January 2018-April 2019
|
Data Capture
Time Frame: Recruitment period January 2018-April 2019
|
This is a feasibility study with a primary objective to establish design of a large multi-centre study.
Outcome measure is number of completed data sets.
A complete data set equals more than one hour of recorded data from mobile fetal heart rate monitor and arterial umbilical cord blood gas level taken.
This will inform estimated sample size for larger study.
|
Recruitment period January 2018-April 2019
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Habiba Kapaya, Sheffield Teaching Hospitals NHS Foundation Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 10, 2018
Primary Completion (ACTUAL)
December 31, 2019
Study Completion (ACTUAL)
December 31, 2019
Study Registration Dates
First Submitted
August 14, 2018
First Submitted That Met QC Criteria
April 17, 2019
First Posted (ACTUAL)
April 22, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 22, 2022
Last Update Submitted That Met QC Criteria
June 20, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- STH19362
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Acidemia
-
Beijing Tongren HospitalCompleted
-
National Taiwan University HospitalUnknownPropionic Acidemia (PA) , Methylmalonic Acidemia (MMA)Taiwan
-
Raydiant Oximetry, Inc.TerminatedFetal Hypoxia | Fetal Distress | Fetal Acidemia | Fetal or Neonatal Effect of Complication of LaborUnited States
-
Recordati Rare DiseasesRecruitingPropionic Acidemia | Methylmalonic AcidemiaFrance, Spain, Italy, United Kingdom, Norway, Germany, Sweden
-
Women and Infants Hospital of Rhode IslandFoundation for Society of Maternal-Fetal MedicineRecruiting
-
CoA Therapeutics, Inc., a BridgeBio companyTerminatedHealthy Volunteers | Propionic Acidemia | Methylmalonic Acidemia | Organic AcidemiaUnited States
-
University of SaskatchewanRecruiting
-
HemoShear TherapeuticsPrometrika, LLC; AllStripes Research Inc.; Genome MedicalTerminatedPropionic Acidemia | Methylmalonic AcidemiaUnited States, Canada, United Kingdom
-
ModernaTX, Inc.CompletedPropionic Acidemia | Methylmalonic AcidemiaUnited States, United Kingdom, Spain, France
-
Target PharmaSolutions, Inc.Recordati Rare DiseasesEnrolling by invitationPropionic Acidemia | Methylmalonic Acidemia | HyperammonemiaUnited States
Clinical Trials on Non-interventional data collection only
-
The Royal Wolverhampton Hospitals NHS TrustRecruitingKnee ArthritisUnited Kingdom
-
Maastricht University Medical CenterVieCuri Medical Centre; Zuyderland Medical CentreCompletedColorectal Neoplasms | Colorectal Cancer | Anastomotic Leak | Colorectal Tumors | Colorectal Carcinoma | Anastomotic LeakageNetherlands
-
University of SheffieldNorthern Health Science Alliance (NHSA)UnknownEmergency and Urgent Care Pathways
-
EpividianRecruitingLiver Diseases | Cardiovascular Diseases | Rheumatic Diseases | Neurodegenerative Diseases | Inflammatory Bowel Diseases | HIV/AIDS | Chronic DiseaseUnited States
-
Hospital Clínico La FloridaCompleted
-
University Health Network, TorontoEnrolling by invitationEhlers-Danlos SyndromeCanada
-
Kobe UniversityHeartFlow, Inc.CompletedCoronary Artery DiseaseJapan
-
Centre Leon BerardInstitut d'Hématologie et d'Oncologie Pédiatrique; Fondation La Roche PosayNot yet recruitingAcute Lymphoblastic Leukemia, Pediatric
-
University of California, Los AngelesCompletedPulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease | Right Heart Pathology